Data from first DMT-assisted clinical trial revealed
Pharma Times
FEBRUARY 24, 2022
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Sat.Feb 19, 2022 - Fri.Feb 25, 2022
170 
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
pharmaphorum
FEBRUARY 21, 2022
Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo’s Enhertu has now shown efficacy in tumours that express lower levels of HER2 – potentially making it an option for a much broader group of patients. It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Report shines a light on unique challenges of rare disease patients
Outsourcing Pharma
FEBRUARY 24, 2022
In its latest diversity, equity and inclusion report, Global Genes offers insight into obstacles faced by rare-disease patients from minority communities.
U.S. House Candidate Apologizes for Behavior at Sleepover
NY Times
FEBRUARY 21, 2022
Parents said Abby Broyles of Oklahoma drank and swore at children at a friend’s home. She said she had mixed wine with medication and had no memory of the night.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Victory Road: NHS successful in 11 year claim against Servier
Pharma Times
FEBRUARY 22, 2022
The European Commission finds that Servier committed a breach of competition over blood pressure drug
NHS gene testing missing half of people at cancer risk
pharmaphorum
FEBRUARY 22, 2022
A study has revealed that current NHS guidelines on testing for genetic alterations linked to cancer could be missing around half of people carrying them, says a new study. The work by scientists at the Institute for Cancer Research (ICR) suggests that access to genetic testing should be made easier because the guidelines as drawn up “would have excluded many people who had ‘actionable’ genetic alterations that could raise their risk of cancer.” Cancer is not usually inhe
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Which pharmaceutical companies have the most drug patents in Slovakia?
Drug Patent Watch
FEBRUARY 25, 2022
This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.
PANORAMIC view of World’s largest COVID study
Pharma Times
FEBRUARY 22, 2022
Study involving 10,000 patients will investigate a range of potentially ground-breaking oral antivirals
Takeda grows in gene therapies again with $2bn Code Bio deal
pharmaphorum
FEBRUARY 23, 2022
Takeda has forged another alliance as it continues a push into gene therapy, agreeing a deal worth up to $2 billion with Code Biotherapeutics for opt-in rights to four candidates for rare diseases. The Japanese drugmaker will get access to Code Bio’s 3DNA non-viral genetic medicine delivery platform, initially for a liver-directed programme, and is also interested in deploying the technology for central nervous system disorders.
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuits
NY Times
FEBRUARY 25, 2022
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be used for addiction treatment and prevention.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Which pharmaceutical companies have the most drug patents in Australia?
Drug Patent Watch
FEBRUARY 22, 2022
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Australia? appeared first on DrugPatentWatch - Make Better Decisions.
CHMP provides initial assessment of Valneva’s COVID-19 vaccine
Pharma Times
FEBRUARY 25, 2022
Valneva expects to receive a positive CHMP recommendation for the conditional approval of its VLA2001 vaccine
How new data capabilities can supercharge clinical research
pharmaphorum
FEBRUARY 24, 2022
The UK’s health research data capabilities are rapidly evolving. For example, during the height of the pandemic, NIHR’s integrated health research system was able to compare COVID-19 hospital caseloads to COVID-19 research activity in real time. This enabled rapid recruitment to multiple COVID-19 clinical trials throughout England/UK. . In a post-pandemic world, how can we use insights gained from healthcare and research activity data to inform commercial research planning and placement decisio
Why Do I Wake Up With a Headache?
NY Times
FEBRUARY 23, 2022
And is there anything I can do to find relief?
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Drug Channels News Roundup, February 2022: Mark Cuban vs. Generics, Novo Nordisk’s G2N, CVS & 340B, and My Favorite Chart
Drug Channels
FEBRUARY 24, 2022
Winter—or at least February—is almost over. Celebrate the imminent return of spring with our selection of noteworthy news from around the drug channel. In this issue: Mark Cuban! Novo Nordisk confronts the gross-to-net bubble CVS Health finally acknowledges its profits from the 340B program Plus, an update to my all-time favorite chart. P.S. Please join the nearly 13,500 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter.
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Pharma Times
FEBRUARY 24, 2022
Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies
5 Situations That Prompt Patients to Engage in Social Health
pharmaphorum
FEBRUARY 23, 2022
Nothing quite compares to the level of solace patients find in connecting with others who share similar health experiences. These interactions have become so fundamental to people living with chronic conditions that a recent Health Union survey of 2,371 patients revealed 95% use online social resources for health reasons. In 2022, social health – the dynamic, real-time actions people take to find meaningful connections and share information throughout the health journey – is more relevant tha
Pharmaceutical companies with the most ‘New Combination’ drugs
Drug Patent Watch
FEBRUARY 24, 2022
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants…. The post Pharmaceutical companies with the most ‘New Combination’ drugs appeared first on DrugPatentWatch - Make Better Decisions.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Genomenon forges rare-disease partnership with advocacy group
Outsourcing Pharma
FEBRUARY 24, 2022
The AI-centered genomics company is joining with Donât Forget Morgan, a group for patients with BPAN, to explore treatments for the neurodegenerative condition.
Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
Pharma Times
FEBRUARY 23, 2022
Researchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal
Your roadmap to getting the most out of meetings
pharmaphorum
FEBRUARY 22, 2022
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. In this post he reinforces good meeting practices to ensure productivity, avoid waste of time and resources and empower everyone to meet the desired business outcomes.
A Re-cap of The Year Ahead: Insights from Pharma Executives
Pharma Marketing Network
FEBRUARY 25, 2022
“ Being more focused, more narrow in terms of the meeting objectives, making sure the right people are there, and making sure that you have quick hit type of interventions during the course of the week to keep track of status is serving us very well. I would suggest that even if and when things return to normal, a lot of those practices and a lot of those mindsets of ways of working will probably continue even after.” – Jeff Fayer, Novartis.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
For rare disease patients, ‘every day is Rare Disease Day’
Outsourcing Pharma
FEBRUARY 21, 2022
On February 23, five days ahead of the day of rare-disease awareness, OSPâs Rare and Orphan Diseases webinar will share insights from top industry experts.
Haleon days: GSK explains demerger decision
Pharma Times
FEBRUARY 23, 2022
New company Haleon will become standalone venture as GSK's strategy for the future unfolds
MindMaze raises $105m to seek out new neurological DTx
pharmaphorum
FEBRUARY 21, 2022
Swiss digital health company MindMaze has raised $105 million to help take its digital therapeutics (DTx) for neurological diseases like stroke onto the global stage, and fund the development of therapies for other diseases like Alzheimer’s and Parkinson’s. MindMaze takes a gaming approach to its DTx platform, but goes well beyond the use of a simple app on a mobile device to develop its therapies.
New patent expiration for J And drug PEPCID AC
Drug Patent Watch
FEBRUARY 25, 2022
Annual Drug Patent Expirations for PEPCID+AC Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. It is available from two suppliers.…. The post New patent expiration for J And drug PEPCID AC appeared first on DrugPatentWatch - Make Better Decisions.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Abzena, Alira Health and Oncodesign launch DRIVE Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation
Pharma Mirror
FEBRUARY 25, 2022
Cambridge, UK, Framingham, MA (USA), and Dijon, France, Abzena, a partner research organization for integrated services from discovery through to clinical and commercial manufacturing for biologics and bioconjugates, Alira Health, an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare, and Oncodesign (ALONC -FR0011766229), a biopharmaceutical company dedicated to precision medicine, announce today that, with the launch of DRIVE™-Biologics,
NHS gene testing fails half of people at cancer risk
Pharma Times
FEBRUARY 21, 2022
Study reveals that many with an increased risk of cancer were excluded from the potential for monitoring
Babraham Institute makes breakthrough in early human embryo research
pharmaphorum
FEBRUARY 25, 2022
A new stem cell model, discovered by researchers exploring the human genome, will help scientists to map out the key genomic changes during early development. The finding, made by the Babraham Institute, Cambridge, will be invaluable in the drive to understand the implications of genome activation errors in developmental disorders and embryo loss, as reported in the journal Cell Stem Cell.
New patent for Rigel Pharms drug TAVALISSE
Drug Patent Watch
FEBRUARY 25, 2022
Annual Drug Patent Expirations for TAVALISSE Tavalisse is a drug marketed by Rigel Pharms Inc and is included in one NDA. There are fourteen patents protecting this drug. This drug…. The post New patent for Rigel Pharms drug TAVALISSE appeared first on DrugPatentWatch - Make Better Decisions.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Let's personalize your content